In Vitro Pharmacodynamic Profile of Loranthus ferrugineus: Evidence for Noncompetitive Antagonism of Norepinephrine-induced Vascular Contraction

JAMS Journal of Acupuncture and Meridian Studies

Volumn 3, Issue 4, 2010, Pages 272-282

  Ameer, Omar Z ^a   Salman, Ibrahim M ^a   Najim, Hafsa S ^a   Abdullah, Ghassan Z ^a   Abdulkarim, Muthanna F ^a   Yam, Mun Fei ^a,b   Sadikun, Amirin ^a   Asmawi, Mohamed Z ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Aortic rings; Double reciprocal plot; Loranthus ferrugineus; Noncompetitve antagonism; Norepinephrine; Pharmacodynamic

Indexed keywords

LORANTHUS FERRUGINEUS EXTRACT; NORADRENALIN; PAPAVERINE; PHENTOLAMINE; PLANT EXTRACT; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HERBAL MEDICINE; HYPERTENSION; IN VITRO STUDY; LORANTHACEAE; MALE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

EID: 78650402408     PISSN: 20052901     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2005-2901(10)60048-9     Document Type: Article

References (26)

1. Fields LE, Burat BL, Cutler JA, Hughes J, Roccella EJ, Sorlie P The burden of adult hypertension in the United States 1999 to 2000. Hypertension 2004, 44:1-7.
2. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913. Prospective studies collaboration.
3. American Heart Association Heart disease and stroke statistics-2004 update, Dallas, Texas [Date accessed: April 8, 2008]. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5306a1.htm.
4. Hardman JG, Limbird LE, Gilman AG Goodman & Gilman's The Pharmacological Basis of Therapeutics 2006, McGraw-Hill, New York. 10th ed.
5. Mashour NH, Lin GI, Frishman WH Herbal medicine for the treatment of cardiovascular disease: clinical considerations. Arch Int Med 1998, 158:2225-2234.
6. Winslow LC, Kroll DJ Herbs as medicines. Arch Intern Med 1998, 158:2192-2199.
7. Barlow B Provisional key to the genera of Loranthaceae and Viscaceae of the flora Malesiana region. Flora Malesiana Bulletin 1992, 10:335-338.
8. Ameer OZ, Salman IM, Yam MF, Abd Allah HH, Abdulla MH, Shah AM, et al. Vasorelaxant properties of Loranthus ferrugineus Roxb. methanolic extract. Int J Pharmacol 2009, 5:44-50.
9. Ameer OZ, Salman IM, Siddiqui MJA, Yam MF, Sriramaneni RN, Sadikun A, et al. Characterization of the possible mechanisms underlying the hypotensive and spasmogenic effects of Loranthus ferrugineus methanolic extract. Am J Chin Med 2009, 37:991-1008.
10. Ameer OZ, Salman IM, Siddiqui MJA, Yam MF, Sriramaneni RN, Sadikun A, et al. In vitro cholinomimetic effect of Loranthus ferrugineus in isolated guinea pig ileum. J Acupunct Meridian Stud 2009, 2:288-293.
11. Ameer OZ, Salman IM, Siddiqui MJA, Yam MF, Sriramaneni RN, Mohamed AJ, et al. Pharmacological mechanisms underlying the vascular activities of Loranthus ferrugineus Roxb. in rat thoracic aorta. J Ethnopharmacol 2010, 127:19-25.
12. Ameer OZ, Salman IM, Siddiqui MJA, Yam MF, Sriramaneni RN, Sadikun A, et al. Cardiovascular activities of n-butanol fraction of Loranthus ferrugineus methanol extract. Braz J Med Biol Res 2010, 43:186-194.
13. Rang HP, Dale MM, Ritter JM Pharmacology 2001, Churchill Livingstone, New York. 4th ed.
14. Howland RD, Mycek MJ Lippincott's Illustrated Reviews: Pharmacology 2006, Lippincott Williams and Wilkins, Philadelphia. 3rd ed.
15. Ameer OZ, Salman IM, Siddiqui MJA, Yam MF, Sriramaneni RN, Mutee AF, et al. Vascular responsiveness to Macrosolen cochinchinensis extracts in isolated rat thoracic aorta. Int J Pharmacol 2009, 5:191-199.
16. Srivastava RC, Nagappa AN Surface Activity in Drug Action 2005, Elsevier Science, Amsterdam. 1st ed.
17. Goldstein I The Vasomax Study Group: Update of safety and efficacy of oral phentolamine (Vasomax) in patients with erectile dysfunction. Int J Imp Res 1999, 11:S71.
18. Zhang S, Zhou Z, Gong Q, Makielski JC, Craig T Mechanism of block and identification of the verapamil binding domain to HERG potassium channels. Circ Res 1999, 84:989-998.
19. Walker KA, Boots MR, Stubbins JF, Rogers ME, Davis CW 1-(4-Aminobenzyl)- and 1-(4-aminophenyl) isoquinolines derivatives: synthesis and evaluation as potential irreversible cyclic nucleotide phosphodiesterase inhibitors. J Med Chem 1983, 28:537-543.
20. Weishaar RR, Burrows S, Kobylarz DC, Quade MM, Evans DB Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Biochem Pharmacol 1986, 35:787-793.
21. Beavo JA Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995, 75:725-747.
22. Ahlner J, Andersson RGG, Torfgárd K, Axelsson KL Organic nitrate esters: clinical use and mechanisms of action. Pharmacol Rev 1991, 43:353-423.
23. Cornwell TL, Lincoln TM Intracellular cyclic GMP receptor proteins. FASEB J 1993, 7:328-338.
24. Schmidt HMMW, Lohmann SM, Walter U The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta 1993, 1178:153-175.
25. Ghayur MN, Gilani AH, Afridi MB, Houghton PJ Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways. Vasc Pharmacol 2005, 43:234-241.
26. Gilani AH, Jabeen Q, Ghayur MN, Janbaz KH, Akhtar MS Studies on the antihypertensive, antispasmodic, bronchodilator and hepatoprotective activities of the Carum copticum seed extract. J Ethnopharmacol 2005, 98:127-135.